Lifestyle changes in pregnant women affected babies' genes

February 11, 2021

A study led by researchers at Lund University in Sweden showed a connection between lifestyle intervention in pregnant women with obesity and epigenetic alterations in the baby. The study is published in the journal Diabetes.

An international collaboration between researchers in Sweden, Denmark and Spain investigated whether children's genes were programmed differently if a pregnant woman with a BMI over 30 underwent lifestyle interventions.

The study involved 425 pregnant women, all of whom have a BMI over 30, which is defined as obesity. They were divided at random into three different groups:The researchers examined the umbilical cord blood of 208 of the newborn babies to see if epigenetic changes had taken place. One way in which epigenetic changes occur is through DNA methylation, in which the activities of nearby genes are changed by molecules that attach to the DNA. Such changes arose in 370 genes at a total of 379 places in the genome, in the children whose mothers were part of the groups that received lifestyle intervention.

Several of the genes that had changed epigenetically regulate metabolism, adipose tissue development and insulin release. It was previously known that several of the altered genes are linked to type 2 diabetes.

"We saw that the babies of mothers in both of the lifestyle-intervention groups, either with physical activity only or with the addition of a healthy diet, had an increased muscle mass at birth, compared with the control group", states Charlotte Ling, a professor at Lund University, who led the study.

The researchers also wanted to find out if the epigenetic changes affected the babies' growth. The children involved in the study were therefore followed up at 9, 18 and 36 months. Twenty-two of the epigenetic changes found are associated with the children's BMI over time.

"In our study we cannot demonstrate a direct causality, but our results suggest that physical activity and a healthy diet during pregnancy in women with obesity affect epigenetics in the newborn babies, and it probably also affects the children's body composition and growth later in life", says Charlotte Ling.

Kristina Renault, an obstetrician and consultant at Rigshospitalet in Copenhagen and one of the researchers behind the study, has previously shown that a lifestyle intervention that includes physical activity with or without a healthy diet leads to reduced weight increase in pregnant women with a BMI over 30. The same group took part in the current study.

"Increased physical activity and a healthy diet during pregnancy can reduce weight increase in pregnant women with obesity, which counteracts some of the otherwise increased risks connected to a high BMI. The fact that the muscle mass of the children appeared to increase and that DNA from the umbilical cord showed epigenetic DNA changes suggests a potentially beneficial programming effect from a healthy lifestyle on the children's health", concludes Kristina Renault.

Lund University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to